Concepedia

R Li

RL

Statistics

Publications

1

Citations

13

H-Index

1

Active since

2009

Affiliations

St. Luke's Medical Center(Current)

R Li is an author at St. Luke's Medical Center specializing in phase iii oncology trials, chemotherapy resistance, and phase iii clinical trials.

Publications per year

2009–2009

1

Publications

1

Ixabepilone plus capecitabine improves progression free survival in patients with metastatic breast cancer resistant to taxanes: a pooled analysis from two phase III trials.

Henri Roché, R Li, J. Ro et al. · Cancer Research · 2009 · 13 citations · Full text

, , +16

1–1 of 1